ADCYAP1 and migraine disorder: A number of findings showed that the clinical expression of migraine is consistent with perivascular trigeminal activation and release of neuropeptides [calcitonin gene-related peptide (CGRP), substance P and pituitary adenylate cyclase-activating polypeptide-38 (PACAP-38)] (59–66).